Introduction: The Next Wave of Pharma Innovation In the life sciences, regulatory content has always played a critical role, yet it has rarely been treated as a strategic asset. Documents such as clinical summaries, regulatory submissions, safety reports, and evidence dossiers are essential for compliance, but they are often viewed as static outputs rather than…
